Menopause: Symptoms, Phases and What Can Really Help
Menopause is not a defect and not a taboo. It is a phase in which your brain learns to cope with less and fluctuating estrogen. When you understand the phases and the mechanism, you can decide more calmly and wisely what may help.
Menopause is too often either dramatized or trivialized. "You just have to get through it" on the one side, "hormones are dangerous" on the other. Neither helps you. I see it this way: menopause is not a failure of your body, but a rebuild. Your brain recalibrates to a new hormonal situation. Some barely feel it, others feel it strongly. This article shows you honestly what happens and which paths exist, without scaremongering and without false promises.
Maybe you know this. You wake at night, drenched in sweat, your heart pounding. During the day a wave of heat sweeps over you out of nowhere, right in the middle of a meeting. Sleep becomes shallow, patience short, and sometimes you feel like a stranger in your own body. You wonder whether it will stay this way. And whether you can do something, or whether you simply have to endure it.
You do not simply have to endure it. In this spoke we look at the whole picture together. What menopause actually is and which three phases it has. Why hot flashes arise in the brain and not in the skin. How to weigh the benefit and risk of hormone therapy honestly. And which levers in daily life, from exercise to behavioral therapy, can make a difference. This article is a spoke in the Hormone Guide and complements the overview of the whole connected hormone system.
The three phases: perimenopause, menopause, postmenopause
Many women experience menopause as one single big something. Yet there are three clearly distinguishable phases. Knowing them helps you place your own situation and understand why the most turbulent time often comes earlier than expected.
Perimenopause
The transition years before the final period. Hormones fluctuate strongly here. Often the most symptom-rich time. Can last four to eight years.
Menopause
A single point in time: the final period. It is only established in hindsight, after twelve months without bleeding.
Postmenopause
The time after that. Hot flashes can persist for years. Complaints in the genital area tend to increase slowly.
The surprising part for many: menopause itself is only a date, not a state. The actual turbulence usually sits in perimenopause. Because there the hormones do not decline gently, they fluctuate. Estrogen can be very high one day and very low a few days later. Your brain has to keep readjusting. That is exactly what is exhausting.
In perimenopause the main problem is not the low hormone level, but the strong fluctuation. Imagine someone constantly turning the volume knob up and down. Even good music becomes a burden that way. Your brain experiences something similar with estrogen. This explains why this phase is so unpredictable, and it is not a sign of weakness.
And now you know why "you are just in menopause" falls short as an explanation. It matters a great deal which phase you are currently in.
The symptom spectrum: far more than hot flashes
When you think of menopause, you probably think first of hot flashes. They are real and common, up to 80 percent of women experience them. But the spectrum is much broader, and many complaints are not connected to menopause.
These include sleep problems, mood dips and irritability, a shorter fuse, joint complaints, heart palpitations, concentration problems and the feeling of inner restlessness. On top of this come complaints in the intimate area that cause silent suffering, because they are rarely mentioned.
The underestimated genitourinary syndrome of menopause
Review Jason Gandhi and colleagues described in 2016 in the American Journal of Obstetrics and Gynecology the genitourinary syndrome of menopause, formerly called atrophic vaginitis. Their central observation: these complaints in the area of the vagina, urinary tract and sexuality affect more than half of women after menopause, but are often not mentioned out of shame and are therefore strongly underdiagnosed. Unlike hot flashes, the syndrome does not disappear on its own but can increase over time. The authors stress that early recognition and individually tailored treatment can clearly improve quality of life.
Gandhi J, Chen A, Dagur G, et al. Am J Obstet Gynecol. 2016;215(6):704-711. doi:10.1016/j.ajog.2016.07.045 · PMID: 27472999
The psyche is also under particular pressure in this phase. Estrogen acts not only on the ovaries but also in the brain, among other things on the serotonin system, which is important for mood and sleep.
How estrogen withdrawal shifts the serotonin system
RCT, double-blind, n=60 Vibe Frokjaer and colleagues investigated in 2015 in Biological Psychiatry what happens when a medication is used to deliberately trigger a hormone drop in healthy women, similar to the one in menopause. They observed that this artificial estrogen withdrawal can trigger mild depressive symptoms and that this went along with measurable changes in the serotonin transporter in the brain. This suggests that mood dips in hormonal transition phases have a real neurobiological basis and are not a character flaw.
Frokjaer VG, Pinborg A, Holst KK, et al. Biol Psychiatry. 2015;78(8):534-543. doi:10.1016/j.biopsych.2015.04.015 · PMID: 26004162
"If I do not have hot flashes, I am not yet in menopause." That is not correct. Many women first notice sleep problems, irritability or mood dips, long before or entirely without hot flashes occurring. The symptom spectrum is individual. Your experience does not have to match the cliché to be real.
And now you know why it is worth knowing the whole spectrum. Otherwise it is easy to miss that seemingly separate complaints can share the same origin.
Why hot flashes arise in the brain
Here comes the part that surprises most people. Hot flashes do not arise in the skin and also not in the ovaries. They arise in the brain, more precisely in the hypothalamus, where your body regulates its temperature.
Imagine the temperature center like a thermostat that keeps your body within a narrow comfort zone. As long as you stay within this window, nothing happens. In the hormonal change of menopause, however, this window becomes much narrower. Even a tiny fluctuation is then interpreted as overheating, and the body hits the emergency brake: skin vessels dilate, you sweat, the heart beats faster.
KNDy neurons and the narrowed temperature window
Review Marie Gombert-Labedens and colleagues summarized in 2025 in the journal Temperature the state of research on temperature regulation in menopause. Their central point: when estradiol declines, certain nerve cells in the hypothalamus, the KNDy neurons, become overactive. These cells project into the temperature center and narrow the range in which the body feels comfortable. Even small triggers then start heat dissipation through vessel dilation and sweating, the typical hot flash. This model also explains why medications that target exactly this circuit can ease hot flashes.
Gombert-Labedens M, Vesterdorf K, Fuller A, et al. Temperature (Austin). 2025;12(2):92-132. doi:10.1080/23328940.2025.2484499 · PMID: 40330614
Exactly this understanding has led to a new class of medications. So-called neurokinin 3 receptor antagonists act directly on this overactive circuit in the brain, without adding hormones. A review by Melissa Conklin and Nanette Santoro described in 2023 in Therapeutic Advances in Reproductive Health how this non-hormonal option can reduce hot flashes, especially for women who cannot or do not want to take hormones (doi:10.1177/26334941231177611, PMID: 37388717).
A hot flash is not a sign that something is wrong with you. It is an oversensitive temperature alarm system. Your brain means well, it wants to cool you down. It is just reacting to a false alarm. This image takes the shame away from many women. You are not too sensitive, your thermostat is currently set too sensitively.
And now you know why the statement "it is only heat" misses the phenomenon. It is neurobiology, and it is treatable.
The four KPNI lenses on menopause
In clinical psychoneuroimmunology, KPNI for short, we look not only at the missing estrogen. We look at four interwoven levels that together explain why one woman barely feels the transition years and another suffers considerably. Each lens explains a part at the cellular level.
Nervous system and temperature
The decisive arena of menopause lies in the brain. Declining estradiol makes the KNDy neurons in the hypothalamus overactive and narrows the temperature window. Estrogen also influences the serotonin system, which steers mood and sleep. This explains why hot flashes, sleep problems and mood dips occur together. It is a nervous system recalibrating itself, not a defect.
Immune system and inflammation
As estrogen declines, the inflammation balance in the body changes. Estrogen acts partly to dampen inflammation, and its decline can promote silent inflammatory processes. This could contribute to joint complaints and an altered pain perception that many women experience anew in this phase. The research on this is still in flux, but the immune system is a real player in the overall picture.
Metabolism and blood sugar
In midlife the metabolism changes. Insulin sensitivity can decrease, fat tends to accumulate around the belly, and blood sugar fluctuates more easily. This is not purely a matter of discipline, but also a consequence of the hormonal change. Stable blood sugar throughout the day therefore relieves not only the metabolism but can also support energy levels and sleep.
Hormone system and bones
Estrogen protects the bone by slowing bone breakdown. After menopause the loss of bone density accelerates, which raises the risk of osteoporosis. The thyroid is also linked to estrogen via binding proteins. Whoever wants to understand menopause has to think of these organs as one connected whole, not as separate departments.
These four lenses are not a theoretical model. They are the reason why sleep, nutrition, exercise and stress regulation in menopause often achieve more than expected. And now you know why a good menopause consultation asks for more than just your hot flashes.
Hormone therapy: the honest benefit-risk assessment
Hardly any medical topic is so shaped by fear and confusion as hormone therapy. The reason lies in the large Women's Health Initiative trials of the early 2000s, whose first headlines unsettled many women. Yet the picture has refined considerably since then.
What became clearer ten years after the WHI trials
Review James Lacey placed the Women's Health Initiative trials in 2013 in the Journal of Steroid Biochemistry and Molecular Biology in an epidemiological context. His central point: the original trials answered a very specific question, namely whether hormone therapy makes sense for the general prevention of chronic diseases in older women. This question was answered no. In the years afterward, however, the closer analysis showed that the timing of the start is decisive. Blanket fear thus did not do justice to the complexity of the topic.
Lacey JV. J Steroid Biochem Mol Biol. 2013;142:12-15. doi:10.1016/j.jsbmb.2013.08.006 · PMID: 24029430
Today's assessment comes from a current guideline recommendation. It shows a much more nuanced picture than the old headlines.
The time window decides on benefit and risk
Consensus Guideline The North American Menopause Society summarized in 2022 in its position statement the state of knowledge on hormone therapy. Core message: for women under sixty or within ten years of menopause without contraindications, the balance of benefit and risk is favorable for bothersome hot flashes and for protection against bone loss. With a start more than ten years after menopause or beyond sixty, however, the absolute risks for cardiovascular events, thrombosis and other problems rise. The therapy should always be weighed individually, considering form, dose, duration and personal history.
The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028 · PMID: 35797481
"Hormones in menopause are fundamentally dangerous." Put so broadly, that is not correct. The benefit-risk ratio depends strongly on age at the start, the form, the dose and your personal history. For many women early in the transition the benefit can outweigh the risks, for others a non-hormonal option is better. This is not a matter of belief, but an individual assessment that belongs in a shared medical decision.
What matters to me is the attitude behind it. Conventional hormone therapy is an effective and well-studied option. It is neither devil's stuff nor a miracle cure. An integrative perspective complements it with the question of how you can support the whole system in parallel. And now you know why the honest answer to "are hormones dangerous" is: it depends.
When hormones are not an option: effective alternatives
Not every woman can or wants to take hormones. After certain cancers, with a thrombosis risk or simply as a personal decision. The good news: there are now effective non-hormonal options, and they are getting better.
First in line are the neurokinin 3 receptor antagonists already mentioned, which act directly on the overactive circuit in the brain.
Fezolinetant against hot flashes, without hormones
RCT, phase 3, n=500 Samuel Lederman and colleagues tested in 2023 in the Lancet, in the SKYLIGHT 1 trial, the active substance fezolinetant, a neurokinin 3 receptor antagonist, in women with at least seven moderate to severe hot flashes per day. Result: compared with placebo, the medication clearly reduced the frequency and severity of hot flashes, with an improvement already after one week. A second, identically designed trial (SKYLIGHT 2, Johnson 2023, Journal of Clinical Endocrinology and Metabolism) confirmed these results. This shows that a targeted non-hormonal treatment at the KNDy circuit can ease hot flashes effectively.
Lederman S, Ottery FD, Cano A, et al. Lancet. 2023;401(10382):1091-1102. doi:10.1016/S0140-6736(23)00085-5 · PMID: 36924778 · Johnson KA et al. J Clin Endocrinol Metab. 2023;108(8):1981-1997. doi:10.1210/clinem/dgad058 · PMID: 36734148
Alongside these there are further non-hormonal paths. A review by Magdalena Pertynska-Marczewska and Tomasz Pertynski described in 2024 in the European Journal of Obstetrics, Gynecology and Reproductive Biology today's range of non-hormonal medications and stressed that for women for whom hormones are not an option, more effective options are available than ever before (doi:10.1016/j.ejogrb.2024.09.013, PMID: 39270577). Behavioral approaches also have a surprisingly good evidence base.
Cognitive behavioral therapy against several complaints at once
RCT, n=71 Sheryl Green and colleagues tested in 2019 in the journal Menopause a cognitive behavioral therapy tailored to menopause. 71 women were either treated or placed on a waiting list. Result: the therapy clearly improved how strongly hot flashes interfered with daily life, and at the same time eased depressive symptoms, sleep problems and sexual complaints. The effects also persisted three months after the end of therapy. This suggests that not only the hot flash itself, but also how you cope with it, can be an effective point of action.
Green SM, Donegan E, Frey BN, et al. Menopause. 2019;26(9):972-980. doi:10.1097/GME.0000000000001363 · PMID: 31453958
And now you know why "no hormones" does not mean "no help." The repertoire has become broader.
Three levers that can support the whole system
Before adjusting individual symptoms, it is worth looking at the foundations. They do not work spectacularly, but they give your body stable conditions while it recalibrates. These three levers are a beginning, not a treatment plan. You can find the individual path with medical guidance.
Move regularly, including strength work
Exercise could improve physical and psychological quality of life in menopause, as reviews show. Strength training also supports bone density, which decreases faster after menopause. You do not have to become an athlete. Even regular walking and a little resistance training can do the whole system good.
Protect sleep and the nervous system
A fixed sleep rhythm and real recovery windows lower the constant activation of the stress system, which is already challenged in this phase. Breathing, walks and screen breaks are not niceties. Behavioral techniques can make coping with nighttime hot flashes easier and thus support sleep.
Have the whole system evaluated
If complaints persist, a diagnostic workup belongs to it that also looks at the thyroid, iron and blood sugar, not just at menopause. This makes it possible to find treatable causes, rather than attributing everything to the hormonal change. A good evaluation takes your complaints seriously.
Exercise and quality of life in menopause
Meta-analysis, k=9 RCTs Thi Mai Nguyen and colleagues evaluated in 2020 in the International Journal of Environmental Research and Public Health nine randomized trials. Their result: exercise improved the physical and psychological quality of life of women with menopause symptoms. For the direct effect on hot flashes the evidence was less clear. A more recent review (Trujillo-Munoz 2025, Healthcare) confirmed the positive effects on vitality and mental health and emphasized that strength training can support bone density.
Nguyen TM, Do TTT, Tran TN, Kim JH. Int J Environ Res Public Health. 2020;17(19):7049. doi:10.3390/ijerph17197049 · PMID: 32993147 · Trujillo-Munoz PJ et al. Healthcare (Basel). 2025;13(6):644. doi:10.3390/healthcare13060644 · PMID: 40150494
For the psyche too there is more than medication. A randomized trial by Jennifer Gordon and colleagues showed in 2021 in Psychoneuroendocrinology that a mindfulness-based stress reduction program could improve depressive symptoms, stress and sleep quality in the menopause transition, especially in women who reacted sensitively to hormone fluctuations (doi:10.1016/j.psyneuen.2021.105277, PMID: 34058560). A further randomized trial from 2024 found that a group-based cognitive behavioral therapy could ease insomnia and depressive symptoms (El-Monshed 2024, doi:10.1111/wvn.12707, PMID: 38329153).
Menopause is a rebuild, not a decline
Your body is not making a mistake. It is adjusting to a new phase of life. You do not have to choose between "enduring" and "fear of hormones." There is a third path: understand the whole system, weigh honestly and decide with good guidance. Your wellbeing in this phase is not a luxury. It is the condition for experiencing the second half of life as your own.
Frequently asked questions about menopause
What are the first signs of menopause?
The first signs often appear in perimenopause, the years before your last period. Typical signs are an irregular cycle, heavier or lighter bleeding, a more pronounced second cycle half with irritability, sleep problems and a new, often hard-to-grasp feeling of inner restlessness. Hot flashes can start early, but do not have to. Many women first notice sleep problems, a shorter fuse and the feeling of becoming a stranger to themselves. Important: these complaints are unspecific and can have other causes, from the thyroid to iron deficiency. Persistent or new symptoms belong in medical evaluation, rather than being attributed to menopause too quickly.
How long do menopause and its symptoms last?
Menopause is not a short episode but a transition over several years. Perimenopause can last four to eight years. Menopause itself is only a single point in time, namely the final period, defined in hindsight after twelve months without bleeding. Postmenopause begins after that. Vasomotor symptoms such as hot flashes last around seven years on average, and considerably longer in some women. The range is wide: some women barely notice anything, others suffer for over a decade. This range is normal and says nothing about strength or weakness, but about the individual sensitivity of the brain to the hormonal change.
Why do hot flashes occur during menopause?
Hot flashes do not arise in the skin but in the brain. The hypothalamus holds a temperature center that keeps the body within a narrow comfort zone. When estrogen declines, certain nerve cells, the KNDy neurons in the so-called arcuate nucleus, become overactive. They send a signal that strongly narrows the comfort zone for body temperature. Even small temperature fluctuations then trigger an emergency response: skin vessels dilate, you sweat, the heart beats faster. That is the hot flash. This model also explains why new, non-hormonal medications that target exactly this circuit can ease hot flashes. Hot flashes are therefore not a sign of weakness, but a misfiring temperature alarm system.
What can really help with menopause symptoms?
There are several levers, and which one fits depends on the symptoms and life situation. Hormone therapy is considered the most effective treatment for hot flashes and the genitourinary syndrome and can protect the bones. For women who cannot or do not want to take hormones, there are effective non-hormonal options, including new neurokinin 3 receptor antagonists. Behavioral approaches such as cognitive behavioral therapy can reduce the burden of hot flashes, sleep problems and depressive symptoms. Exercise can improve quality of life and mental health. From an integrative perspective, it is worth looking at the whole system: sleep, blood sugar, stress, thyroid and iron. You can best find the individual path with medical guidance.
Is hormone therapy dangerous?
The answer is more nuanced than past headlines suggest. After the reassessment of the large Women's Health Initiative trials, the benefit-risk ratio depends strongly on the timing of when therapy starts. For women under sixty or within ten years of menopause who have no contraindications, the balance of benefit and risk is considered favorable for bothersome hot flashes and for protection against bone loss. With a later start, meaning more than ten years after menopause or beyond sixty, the absolute risks for cardiovascular events and other problems rise. The therapy should therefore always be weighed individually, considering form, dose, duration and personal history. That belongs in a shared medical decision.
What phases does menopause have?
Menopause is divided into three phases. Perimenopause is the transition with the first irregularities, in which hormones fluctuate strongly. Menopause is the single point in time of the final period, which is only established in hindsight after twelve bleeding-free months. Postmenopause is the time after that. It is important that perimenopause is often the most symptom-rich phase, precisely because hormones do not simply decline here but fluctuate strongly. Many women expect symptoms only after the final period and are surprised that the years before can be more turbulent. Knowing the phases helps you place your own situation.
Can exercise and lifestyle help with menopause symptoms?
Yes, lifestyle is a real lever, even if it is no cure-all. Studies show that exercise can improve physical and psychological quality of life during menopause, even if the direct effect on hot flashes is less clearly proven. Strength training can also support bone density, which is especially important after menopause. Stable blood sugar throughout the day, protected sleep and stress regulation relieve the nervous system, which is already challenged in this phase. From the perspective of clinical psychoneuroimmunology, the aim is to give the body the most stable conditions possible while it recalibrates. This does not replace medical treatment but can sensibly complement it.
What is the genitourinary syndrome of menopause?
The genitourinary syndrome of menopause is a term for complaints in the area of the vagina, urinary tract and sexuality that can arise from estrogen decline. These include dryness, burning, pain during sex and more frequent urinary complaints. It affects more than half of women after menopause but is often not mentioned out of shame and is therefore underdiagnosed. Unlike hot flashes, it does not disappear on its own but can increase over time. There are effective options, including low-dose local estrogen preparations as well as non-hormonal moisturizers and lubricants. It is important that you raise the topic, because it is common, treatable and no reason for shame.
Why do mood dips and sleep problems occur during menopause?
The hormones of the cycle act not only on the ovaries but also on the brain. Estrogen influences, among other things, the serotonin system, which is important for mood and sleep. In perimenopause, estrogen fluctuates strongly, and this fluctuation can promote depressive symptoms in sensitive women. Research suggests that not the low level alone, but the individual sensitivity to the hormonal change is decisive. Sleep problems arise partly directly from nighttime hot flashes, partly from the altered brain chemistry. This means: mood dips in this phase are not a character flaw but have a neurobiological basis. Persistent or severe depressive symptoms belong in medical evaluation.
When should I see a doctor about menopause symptoms?
Many menopause symptoms are distressing but not dangerous. Still, no online text replaces medical evaluation. You should urgently have evaluated any bleeding that recurs after menopause, very heavy or unusual bleeding in perimenopause, as well as severe depressive moods with hopelessness. Also, if hot flashes, sleep problems or mood dips noticeably impair your quality of life, the conversation is worthwhile, because there are effective options. A good evaluation looks at the whole system and also checks the thyroid, iron and blood sugar, rather than attributing everything to menopause. If you have thoughts of no longer wanting to live, please get help immediately.
All topics in the "Hormone Guide" cluster
This spoke is part of the cluster around female hormones. Here you find the pillar and all related topics.
- Hormonal Imbalance in Women (overview/pillar)
- Estrogen dominance: recognizing symptoms and addressing them naturally
- Xenoestrogens: hormone disruptors in daily life
- Coming off the pill: what happens in the body
- Progesterone deficiency: symptoms and test
- PMS: symptoms and what can help
- PMDD: when PMS hits the psyche
- Perimenopause: symptoms and from when
- Menopause: symptoms and what can help
- PCO syndrome: causes and symptoms
- Hormonal acne from within
- Endometriosis: an integrative view
- Hormone-free contraception compared
- Loss of libido in women
- Testing hormones: which test, when
- Lowering estrogen naturally (the liver)
- Cycle-based nutrition
- The thyroid and female hormones
- Insulin resistance and hormones
- Cortisol, stress and female hormones
- Chaste tree and herbal hormone helpers
Connections to other topics
Many menopause complaints resemble a borderline thyroid. Why it is worth looking at both together.
The stress system is especially challenged during menopause. An honest assessment of cortisol and the HPA axis.
Iron deficiency amplifies exhaustion and sleep problems that can look like pure menopause complaints.
The gut influences, via the immune system and the estrogen metabolism, how well your body gets through the rebuild.
Why women over 40 respond differently to fasting and how the hormonal change of menopause plays a role.
The question of contraception also arises in perimenopause. An honest look at possible complaints.
Sources and further reading
- Gombert-Labedens M, Vesterdorf K, Fuller A, et al. Effects of menopause on temperature regulation. Temperature (Austin). 2025;12(2):92-132. doi:10.1080/23328940.2025.2484499 · PMID: 40330614 [Review]
- Conklin M, Santoro N. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause. Ther Adv Reprod Health. 2023;17:26334941231177611. doi:10.1177/26334941231177611 · PMID: 37388717 [Review]
- Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023;401(10382):1091-1102. doi:10.1016/S0140-6736(23)00085-5 · PMID: 36924778 [RCT, n=500]
- Johnson KA, Martin N, Nappi RE, et al. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT (SKYLIGHT 2). J Clin Endocrinol Metab. 2023;108(8):1981-1997. doi:10.1210/clinem/dgad058 · PMID: 36734148 [RCT]
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028 · PMID: 35797481 [Consensus Guideline]
- Lacey JV. The WHI ten year's later: an epidemiologist's view. J Steroid Biochem Mol Biol. 2013;142:12-15. doi:10.1016/j.jsbmb.2013.08.006 · PMID: 24029430 [Review]
- Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704-711. doi:10.1016/j.ajog.2016.07.045 · PMID: 27472999 [Review]
- Green SM, Donegan E, Frey BN, et al. Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial. Menopause. 2019;26(9):972-980. doi:10.1097/GME.0000000000001363 · PMID: 31453958 [RCT, n=71]
- El-Monshed AH, Khonji LM, Altheeb M, et al. Does a program-based cognitive behavioral therapy affect insomnia and depression in menopausal women? A randomized controlled trial. Worldviews Evid Based Nurs. 2024;21(2):202-215. doi:10.1111/wvn.12707 · PMID: 38329153 [RCT, n=88]
- Nguyen TM, Do TTT, Tran TN, Kim JH. Exercise and Quality of Life in Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Environ Res Public Health. 2020;17(19):7049. doi:10.3390/ijerph17197049 · PMID: 32993147 [Meta-analysis]
- Trujillo-Munoz PJ, Sanchez-Ojeda MA, Rodriguez-Huaman EC, et al. Effects of Physical Exercise on Symptoms and Quality of Life in Women in Climacteric: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2025;13(6):644. doi:10.3390/healthcare13060644 · PMID: 40150494 [Systematic Review]
- Gordon JL, Halleran M, Beshai S, et al. Endocrine and psychosocial moderators of mindfulness-based stress reduction for the prevention of perimenopausal depressive symptoms: A randomized controlled trial. Psychoneuroendocrinology. 2021;130:105277. doi:10.1016/j.psyneuen.2021.105277 · PMID: 34058560 [RCT, n=104]
- Pertynska-Marczewska M, Pertynski T. Non-hormonal pharmacological interventions for managing vasomotor symptoms-how can we help: 2024 landscape. Eur J Obstet Gynecol Reprod Biol. 2024;302:141-148. doi:10.1016/j.ejogrb.2024.09.013 · PMID: 39270577 [Review]
- Frokjaer VG, Pinborg A, Holst KK, et al. Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study. Biol Psychiatry. 2015;78(8):534-543. doi:10.1016/j.biopsych.2015.04.015 · PMID: 26004162 [RCT, n=60]